Hepatocellular carcinoma remains a substantial global public health concern, disproportionately affecting low-income and middle-income countries, particularly in Africa.1 Its burden in Africa is ...

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to ...

First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025; UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of Euro ...

A Mediterranean diet during pregnancy significantly alters the maternal gut microbiome, increasing beneficial bacteria, while ...

If we've got vaccines for so many other viruses - including Covid-19, which emerged only a few years ago - why don't we have ...

Fecal microbiota transplantation in long-term care patients shows safety and potential to lower infection rates, despite ...

Inclusion isn’t just about eligibility; it’s about participation Trials often demand time, travel and flexibility, resources ...

TUESDAY, Aug. 5, 2025 (HealthDay News) — A large new study will follow the health and well-being of thousands of transgender ...

Emory’s Sagar Lonial, MD, a world-class leader in his specialty, harnesses teamwork to advance the treatment of multiple ...

A Harvard Business School Healthcare Alumni Association Q&A with Stephanie J. Creary, Assistant Professor of Management at ...

Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) ...